EDGAR Filing Documents for 0001415889-16-006694

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001415889-16-006694

Filing Date

2016-08-05

Accepted

2016-08-05 11:14:06

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 2 TO FORM S-1	azurrxs1a-am2_aug2016.htm	S-1/A	2090780
2		azurrx_logo.jpg	GRAPHIC	17637
3	FORM OF UNDERWRITER WARRANT	ex4-3.htm	EX-4.3	109875
4	CONSENT OF WEISERMAZARS LLP	ex23-1.htm	EX-23.1	2876
	Complete submission text file	0001415889-16-006694.txt		2228998

Mailing Address 760 PARKSIDE AVENUE SUITE 217 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 217 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-1/A | Act: 33 | File No.: 333-212511 | Film No.: 161809654
SIC: 2834 Pharmaceutical Preparations